Venture capital firm GGV Capital has led a RMB100 million (US$15.7 million) series B round in Shanghai-based artificial intelligence-powered medical data solutions provider Synyi. Existing investors including Sequoia Capital China and Zhen Fund also participated in the round, according to GGV’s announcement on its official WeChat account. Synyi  focuses on processing  medical data to serve smart medical systems. It uses natural language processing technology to structure and standardize medical related texts, including lexical analysis, syntactic analysis, semantic analysis, structured expression, and standardized mapping.